Experience of on-site disposal of production uranium-graphite nuclear reactor.

The paper reported the experience gained in the course of decommissioning EI-2 Production Uranium-Graphite Nuclear Reactor. EI-2 was a production Uranium-Graphite Nuclear Reactor located on the Production and Demonstration Center for Uranium-Graphite Reactors JSC (PDC UGR JSC) site of Seversk City, Tomsk Region, Russia. EI-2 commenced its operation in 1958, and was shut down on December 28, 1990, having operated for the period of 33 years all together.

[Personalized cell therapy for early postoperative bullous keratopathy (experimental proof and clinical results)].

The article presents the results of a long-term research on development and clinical application of personalized cell therapy (PCT) for treatment of early postoperative (manifesting within the first 3 months after surgery) bullous keratopathy (BK). The method of intracameral PCT implies in vitro incubation of the patient's blood sample with poly(A:U) stimulator, separation of the serum with activated leukocytes, and injection of the final cell preparation into the anterior chamber. The fundamental part of the research was aimed at a detailed description of the cell preparation and investigation of its possible mechanisms of action.

[Study of the three-dimensional structure and biointegrative characteristics of porous orbital implant materials].

Plastic repair operations in ophthalmic surgery frequently require the use of various biological and artificial implants. The biointegrative properties of implants are provided by the physicochemical characteristics of the material that is used to make them, by the three-dimensional structure of an implant and its immunological characteristics. The authors comparatively studied the three-dimensional structure of a Carbotexim-M carbonic felt, porous polyethylene, polytetrafluoroethylene, demineralized bone alloimplant, and marine coral hydroxyapatite, which are employed in orbital surgery and also examined the adhesion of fibroblasts to their surface.

[Pavlyuk--antioxidant "Gistochrom" in the complex treatment of intraocular hemorrhages in children].

We studied the efficiency of Russian antioxidant Gistochrom in the treatment of intraocular hemorrhages of different genesis in children. Gistochrom was used in 407 children (449 eyes), aged 1 month to 14 years, with traumatic hyphema, hemophthalmos, hemorrhages in the eye bottom, hemorrhagic retinovasculitis, recurrent hephema, diabetic retinopathy, hemorrhages after reconstruction of the anterior chamber with cataract extraction, neuritis, retinopathy of prematures as well as with uveitis with a pronounced exudative component, with signs of retinal edema and of reactive pappilitis. Gistochrom has an intense action on blood resorption in structures of the eye ball as observed in traumas and lesions of internal eye tunics with hemorrhages.

[Quant therapy and the composition of the moister of the eye anterior chamber (an experimental study)].

We examined 12 rabbits, 6 of whom (12 eyes) were exposed to magneto-infrared laser radiation (MILR) and another 6 (12 eyes) were controls. The parameters of pulse and continuous infrared LED radiation were as follows: wavelength--860 nm, pulse capacity--2 W, mean radiation capacity--10 mW, magnetic field strength--up to 17 mTl. A study of the moister of the anterior chamber showed a MILR-induced activated metabolism, i.